State officials announced Monday the recipients of Kentucky's most recent round of funding for high-tech small businesses. Eleven of them are in Central Kentucky.
In all, 17 Kentucky-based companies will share $6.2 million in funding as part of a program that matches awards, up to a certain amount, from two federal grant programs: Small Business Innovation Research and Small Business Technology Transfer. The state offers as much as $150,000 for Phase 1 federal awards for the grants and as much as $500,000 a year for as long as two years for Phase 2 federal awards.
The state's matching-funds program will begin accepting applications for a new round of grants from April 1 to 30. To learn more, go to Thinkkentucky.com/dci/SBIR.
Never miss a local story.
Central Kentucky companies announced as recipients Monday were:
3H Co. of Lexington, $232,212: Development of technology related to the capture and storage of carbon dioxide underground.
AllTranz Inc. of Lexington, $150,000: Development of treatments of various neurological disorders.
AMT nano of Lexington, $90,000: Development of micro-robots to be used in medical devices and aerospace and defense applications.
ATI Inc. of Lexington, $98,748: Development of aluminum alloy weld wiring to be used in items ranging from armored military vehicles to commercial bikes.
customKYnetics Inc. of Versailles, $494,458: Development of an electrical-stimulation device for use by people including those doing orthopedic rehabilitation.
Invenio Therapeutics Inc. of Lexington, $434,480: Development of an improved therapy for patients who have acute myeloid leukemia.
nGimat of Lexington, $750,754: Development of nanomaterials for use in advanced lithium-ion automotive batteries for electric vehicles, and in energy-storage components for the emerging electrical smart grid.
Orthopeutics LP of Lexington, $359,400: Development of non-surgical solutions for common orthopedic problems.
ParaTechs Corp. of Lexington, $459,478: Development of mice used in biotechnology discovery and development.
Transposagen Biopharmaceuticals Inc. of Lexington, $500,000: Development of laboratory rats that can mimic human diseases.
W-Z BioTech of Lexington, $150,000: Development of a non-surgical medical device to manage heart failure.